goto Indian Health Service home page  Indian Health Service:  The Federal Health Program for American Indians and Alaska Natives

 
IHS HOME ABOUT IHS SITE MAP HELP
goto Health and Human Services home page goto Health and Human Services home page

Thyroid Disorders in Pregnancy

Contact Us

MCH Website Administrator

Required Plugins

These plug-ins
may be required
for the content
on this page:


Link to Adobe Acrobat Plug-in Acrobat
Link to MicroSoft Word Plug-in MS Word

IHS Plug-in Page

Use site contact
if unable to view
a particular file

Maternal Child

Maternal Child HealthPerinatologist Corner ‹ C.E.U./C.M.E. Modules

Perinatologist Corner - C.E.U/C.M.E. Modules

Thyroid Disorders in Pregnancy

Sponsored by The Indian Health Service Clinical Support Center

 

1 How to participate

For more details about how to participate in this C.E.U ./ C.M.E. program, see the Perinatologist Corner page. Also see specifics there on Goals, Sponsorship and Credit, and Disclosure .

 

Step 1: Goals and objectives

The student will understand the maternal and fetal consequences, methods and limitations of screening, and understand thyroid disorders in pregnancy .

Objectives

The objectives for this module are:

  • The student will understand the maternal and fetal consequences of thyroid disorders in pregnancy
  • The student will understand the methods and limitations of thyroid disorders in pregnancy
  • The student will understand the management of thyroid disorders in pregnancy

Case scenario

Agnes Naakai is a 34 y/o G3P2 at 19 weeks gestation with known hypothyroidism who is taking levothyroxine 0.2 mg daily. She has no complaints. Physical examination is unremarkable. Her initial thyroid functions are reported as follows:

TSH: 17.2 mIU/mL (nl: 0.46-4.68)

Free T4: 0.70 ng/dL (nl: 0.78-2.19)

Should you take any action? What would be most appropriate?

 

 

 

 

Next › 2. Background

up arrow Return to top of page